(Q43711826)

26 November 2017

Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure - a substudy to the MERIT-HF trial. (English)

1 reference

26 November 2017

chronic heart failure

1 reference

1

Gullestad L

1 reference

26 November 2017

7

Kjekshus J

1 reference

26 November 2017

Manhenke C

2

1 reference

26 November 2017

Aarsland T

3

1 reference

26 November 2017

Skårdal R

4

1 reference

26 November 2017

Fagertun H

5

1 reference

26 November 2017

Wikstrand J

6

1 reference

26 November 2017

1 August 2001

1 reference

European Journal of Heart Failure

26 November 2017

1 reference

26 November 2017

3

1 reference

26 November 2017

463-468

1 reference

26 November 2017

4

1 reference

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Effects of beta-adrenergic blockade on the cardiac response to maximal and submaximal exercise in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Effect of beta-adrenoceptor blockade on exercise performance and metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Beta-blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Blockade of isoprenaline-induced changes in plasma free fatty acids, immunoreactive insulin levels and plasma renin activity in healthy human subjects, by propranolol, pindolol, practolol, atenolol, metoprolol and acebutolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Can physicians always explain the results of clinical trials? A case study of amlodipine in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

7 January 2021

Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

7 January 2021

Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

7 January 2021

Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

7 January 2021

Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

7 January 2021

Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

7 January 2021

Serial exercise testing and prognosis in selected patients considered for cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1388-9842%2801%2900146-5

7 January 2021

10.1016/S1388-9842(01)00146-5

Identifiers

DOI

1 reference

26 November 2017

1 reference